NYSEMKT: ATNMActinium Pharmaceuticals Inc Stock Ownership - Who owns Actinium Pharmaceuticals?
Insider buying vs selling
Have Actinium Pharmaceuticals Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when ATNM insiders and whales buy or sell their stock.
ATNM Shareholders
What type of owners hold Actinium Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Diane S. Button | 63.61% | 20,000,000 | $27.60M | Insider |
| Sloan Kettering Cancer Center Memorial | 33.12% | 10,411,948 | $14.37M | Insider |
| Sandesh Seth | 6.25% | 1,965,355 | $2.71M | Insider |
| Matthew T. David | 0.80% | 250,000 | $345.00k | Insider |
| Adeela Kamal | 0.68% | 213,648 | $294.83k | Insider |
| Steffen Wilhem Heeger | 0.49% | 153,868 | $212.34k | Insider |
| Kaushik J. Dave | 0.28% | 88,500 | $122.13k | Insider |
| C. David 1. Nicholson | 0.20% | 63,300 | $87.35k | Insider |
| Richard I. Steinhart | 0.20% | 63,116 | $87.10k | Insider |
| Ajit Shetty | 0.20% | 62,357 | $86.05k | Insider |
ATNM vs Biotech Stocks
Actinium Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.